A Study to Evaluate the Safety and Tolerability of Multiple Intravenous Doses of MEDI 545 in Patients With Systemic Lupus Erythematosus
Clinical trial NCT00482989 · COMPLETED
Trial details
- NCT number
- NCT00482989
- Sponsor
- MedImmune LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-06-01
- Primary completion
- 2010-07-01
- Enrollment
- 183
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.